XS Financial Amends Unsecured Convertible Notes, Extends Maturity Date

XS Financial Inc. (OTCQB: XSHLF) (CSE:XSF) has amended its unsecured convertible notes in the aggregate principal amount of $43.5 million, which were originally issued on October 28, 2021 and October 10, 2022.

XS Financial Inc. (OTCQB:XSHLF) (CSE:XSF) has amended its unsecured convertible notes in the aggregate principal amount of $43.5 million, which were originally issued on October 28, 2021 and October 10, 2022.

The notes were originally scheduled to mature on October 28, 2023, subject to a one-year extension in certain circumstances. Pursuant to the terms of the amendment, the notes will now mature on either December 31, 2024 if the company secures a written commitment by one or more third party lenders prior to December 31, 2023, providing for the advance of senior indebtedness to the company in an aggregate minimum principal amount of $50 million; or otherwise, June 30, 2024. The company has the option of extending the December maturity date for an additional one-year period to December 31, 2025, by providing written notice to the note holders and making a cash payment equal to 1% of the aggregate principal amount of the notes outstanding at the date of such notice.

In addition, the amendments provide that the principal and interest outstanding under the notes may be converted by the holders into subordinate voting shares of the company at a conversion price equal to the lesser of: CA$0.12 per share; or 80% of the offering price per security in a “qualified offering” as defined therein; provide that interest on the notes will accrue at the rate of 9.50%per annum, of which 7.00% shall be payable in cash and the remaining 2.50% shall be payable in kind by the issuance of additional notes, subject to adjustment in certain circumstances; remove a restriction providing that the ratio of total indebtedness to tangible net worth of the company, shall not be greater than 4.25 to 1.0, all as further detailed therein; and and give effect to certain other housekeeping amendments.

Photo: Benzinga edit with photo by Kindel Media on Pexels

Total
0
Shares
Related Posts
Read More

Myriad Genetics Announces Reorganization Of European Operations And Sale Of EndoPredict Business; No Financial Terms Disclosed, Deal Is Subject To Customary Closing Conditions, Expects The Transaction To Close In Q2 Or Q3 Of 2024.

Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced the reorganization of its European operations to better align company resources to its domestic opportunities

MYGN

Read More

Iteris Awarded Multi-Year $2.5M Contract By San Bernardino County Transportation Authority For Signal Coordination Support And Development Of Smart County Master Plan; Will Include A Smart County Roadmap For The Largest County In The U.S.

This multi-year, $2.5 million contract will include a Smart County roadmap for the largest county in the United States Iteris, Inc. (NASDAQ:ITI), the world's trusted technology ecosystem for smart mobility

ITI